About Us
World Leaders in Biomarker and Bioanalysis Research Services
A thesis developed by Synexa, integrating discrete components to form a connected whole.
Insight into the biology of immunogenicity and its role in drug development.
About Us
World Leaders in Biomarker and Bioanalysis Research Services
A thesis developed by Synexa, integrating discrete components to form a connected whole.
NanoString nCounter Technology – COVID-19 Immunological and Inflammatory Response
About Us
World Leaders in Biomarker and Bioanalysis Research Services
A thesis developed by Synexa, integrating discrete components to form a connected whole.
Lack of implantation of an embryo: when the numbers count
About Us
World Leaders in Biomarker and Bioanalysis Research Services
A thesis developed by Synexa, integrating discrete components to form a connected whole.
SARS-CoV-2: when does the calm become the perfect storm?
Previous
Next
Biomarker & Bioanalytical expertise
Synexa Life Sciences has been providing expert insights for the clinical development of therapeutics for almost 20 years.
Biomarker Science
Insights that will improve the quality of decision-making through each stage of a therapeutic’s development.
Bioanalytical Science
Invaluable insight into the bioanalytical profile of large molecule therapeutics.
Research & Development
An expanding series of R&D programs that form the foundation for future services and products.
VECTORS
Vectors are objects which have both magnitude and direction.
- February 15, 2021
The Biomarker Association between Depression and Vascular Disease
- February 15, 2021
Infertility and the importance of the endometrial immune balance
- September 18, 2020
Th17 Cells and IL-17: a possible link between inflammation and neuronal decline in Multiple Sclerosis
- September 18, 2020
Spot on: Use of Dried Blood Spots (DBS) for serological immunoassays
- September 18, 2020
Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain
- September 18, 2020
The prospect of immunotherapy for combating Alzheimer’s disease
Clinical Trials
The value of biomarkers
biomarker science |